The transaction is expected to close at the end of March 2012.
KCR will be combined with inVentiv’s existing functional service provider (FSP) and staffing businesses within the Clinical segment.
The combined organization will utilize inVentiv Health’s global reach, to meet clients’ strategic resourcing needs in more than 40 countries.
KCR’s range of clinical services include site management and monitoring, clinical programming and data management, clinical project and program management, biostatistical analysis and reporting, pharmacovigilance, medical writing, regulatory affairs.
inVentiv Health CEO Paul Meister said Kforce Clinical Research is an attractive complement to the company’s existing services.
"This acquisition expands our capability across the continuum of FSP, staffing and CRO services, further enhancing our ability to deliver flexible, cost-effective solutions for our clients," Meister added.